As Brain Tumour Awareness Month comes to an end, we are pleased to have been supported by a number of politicians on Twitter.
Amongst those voicing their support was Jonathan Ashworth, the Shadow Secretary of State for Health and Social Care, who said: “I want to take this opportunity to support @braintumourrsch who campaign to bring awareness and research funding to this condition that affects so many.”
Helen Hayes, an officer for the APPG on Brain Tumours (APPGBT), donated to support #WearAHatDay on Friday and shared her hat selfie, writing: “In memory of my grandparents George and Olive Hayes who both passed away due to a brain tumour.”
George Freeman MP, who famously responded for the Government after the 2016 Westminster Hall debate that followed the Realf e-petition and announced the setting up of the Department of Health and Social Care (DHSC) working group on brain tumours, tweeted: “I'm proud to be supporting @braintumourrsch today for #WearAHatDay.”
He was joined by other supportive MP’s including Ben Everitt, Chris Philp, Rachel Hopkins, Emma Lewell-Buck, Mary Glindon, Robert Buckland and Alan Campbell, who was one of a number of Parliamentarians to add to their tweet that it is “time for the Government to invest more into brain cancer research”.
Coming after last Wednesday’s Prime Minister’s Questions when the PM, Boris Johnson, agreed to meet with the Chair of APPGBT, Derek Thomas MP, to look at our #braintumourrpetition report, these are exciting times.
Hugh Adams, our Head of Stakeholder Relations, said: “We are a campaigning charity and have always been clear that we want to work with Government. To see a growing number of Parliamentarians supporting the cause of brain tumour research is gratifying but it has also been a long time coming. We won’t be taking our foot off the pedal – brain tumour patients don’t have the luxury of time.”
Campaigning milestone: PM to receive our brain tumour petition
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.